The new article provides additional clarifications regarding the specific scope of information-related obligations medical device manufacturers should comply with.
The final article of the cycle clarifies certain specific regulatory matters associated with submissions, such as the applicability of transitional provisions or modifications to submissions and the way they should be introduced.
The new article further describes in detail the specific approach to be followed when making a submission, highlighting the key points to be considered by the parties involved.